papaverine has been researched along with furosemide in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fisch, U; Yagi, N | 1 |
| Blaine, EH; Zimmerman, MB | 1 |
| Blaine, EH | 1 |
| Bailie, MD; Corsini, WA; Hook, JB | 1 |
| Klaus, W; Krebs, R; Seitz, N | 1 |
| Engelmann, K; Petter, A; Schenkel, R | 1 |
| Kellerhals, B | 1 |
| Lehtonen, T | 1 |
| Geller, M; Luzes, RM; Sekeff, JA; Soares, RV; Souza, PJ | 1 |
| Ferrero, A; Marzullo, C; Salmoiraghi, ML | 1 |
| Formanek, K; Lindner, A; Selzer, H | 1 |
| Lush, DJ; Munday, KA; Noble, AR | 1 |
| Levy, M; McCaffrey, C | 1 |
| Burkhoff, D; Gu, A; Keren, G; Shimizu, J; Suehiro, K; Wang, J; Yi, GH | 1 |
| Ambrus, R; Horváth, P; Szabó-Révész, P; Szőke, V; Takács-Novák, K; Völgyi, G | 1 |
1 review(s) available for papaverine and furosemide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for papaverine and furosemide
| Article | Year |
|---|---|
Passage of ureteral concretions. A clinical and experimental study on the role of different therapeutic methods and urinary tract infection on the passage of ureteral concretions.
Topics: Aminophylline; Animals; Anti-Infective Agents, Urinary; Cystoscopy; Diuresis; Female; Furosemide; Humans; Male; Nephrectomy; Oxyphenbutazone; Papaverine; Piperidines; Placebos; Theophylline; Ureteral Calculi; Ureteral Diseases; Urinary Tract Infections; Urine; Urography | 1972 |
[Therapeutic evaluation of uncomplicated hypertensive crises in emergencies].
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Emergencies; Evaluation Studies as Topic; Furosemide; Humans; Hypertension; Methods; Middle Aged; Papaverine; Placebos; Reserpine | 1972 |
23 other study(ies) available for papaverine and furosemide
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Vasoactive drugs and oxygen content in the perilymph (author's transl)].
Topics: Angiotensin II; Animals; Cats; Dextrans; Furosemide; Glycerol; Histamine; Labyrinthine Fluids; Nicotinyl Alcohol; Oxygen Consumption; Papaverine; Perilymph; Vasoconstrictor Agents; Vasodilator Agents | 1978 |
Renal function and renin secretion after administration of ouabain and ouabain plus furosemide in conscious sheep.
Topics: Animals; Epinephrine; Furosemide; Kidney; Ouabain; Papaverine; Potassium; Renin; Sheep; Sodium | 1978 |
Renin secretion after papaverine and furosemide in conscious sheep.
Topics: Animals; Blood Pressure; Drug Interactions; Furosemide; Glomerular Filtration Rate; Kidney; Papaverine; Regional Blood Flow; Renin; Sheep; Sodium; Wakefulness | 1977 |
Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors.
Topics: Acetylcholine; Animals; Dogs; Furosemide; Juxtaglomerular Apparatus; Kidney; Kidney Tubules, Distal; Male; Papaverine; Pressoreceptors; Propranolol; Renin; Stimulation, Chemical; Sympathetic Nervous System; Vascular Resistance | 1975 |
[Dissociation of function and metabolism of the isolated guinea pig heart under the influence of phosphodiesterase inhibitors].
Topics: Animals; Coronary Vessels; Enzyme Activation; Ethacrynic Acid; Furosemide; Glucosyltransferases; Glycogen; Guinea Pigs; Heart; Hydrochlorothiazide; In Vitro Techniques; Lactates; Myocardium; Oxygen Consumption; Papaverine; Perfusion; Phosphoric Monoester Hydrolases; Pyruvates; Stimulation, Chemical; Theophylline | 1970 |
[Effect of several saluretic agents on smooth muscle. A contribution to the varied effects of saluretic agents on glomerular filtration (author's transl)].
Topics: Animals; Chlorthalidone; Diuretics; Female; Furans; Furosemide; Glomerular Filtration Rate; Hemodynamics; Hydrochlorothiazide; Inulin; Kidney; Kidney Function Tests; Male; Muscle Contraction; Norepinephrine; Papaverine; Rats; Receptors, Adrenergic; Vas Deferens | 1974 |
Pharmacology of perilymph production.
Topics: Acetazolamide; Acidosis, Respiratory; Adenosine Triphosphate; Albumins; Animals; Dextrans; Dihydroergotamine; Dihydroergotoxine; Ear Diseases; Ear, Inner; Ethacrynic Acid; Furosemide; Guinea Pigs; Labyrinthine Fluids; Nicotinyl Alcohol; Papaverine; Perilymph | 1974 |
[Intensive therapy of gestoses. Our experience in the years 1969-1971].
Topics: Betamethasone; Brain Edema; Diazepam; Ergoloid Mesylates; Female; Furosemide; Humans; Mannitol; Papaverine; Phytotherapy; Plants, Medicinal; Pre-Eclampsia; Pregnancy; Rauwolfia; Thiopental | 1971 |
[Effect of spasmolytic agents on the bladder evacuation time in rats].
Topics: Animals; Atropine; Diuresis; Furosemide; Metabolic Clearance Rate; Papaverine; Parasympatholytics; Physostigmine; Rats; Strychnine; Time Factors; Urinary Bladder; Urination | 1971 |
Furosemide fails to alter plasma active or inactive renin in conscious sheep but does so in anaesthetized animals.
Topics: Anesthesia, Intravenous; Animals; Blood Pressure; Consciousness; Creatinine; Diuresis; Furosemide; Papaverine; Pentobarbital; Potassium; Renin; Sheep; Sodium | 1983 |
Effect of furosemide on thoracic duct lymph flow in the dog.
Topics: Abdomen; Angiotensin II; Animals; Blood Proteins; Calcium; Dogs; Extracellular Space; Female; Furosemide; Isoproterenol; Kidney; Lymph; Male; Papaverine; Regional Blood Flow; Saralasin; Sodium Nitrite; Thoracic Duct | 1980 |
Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.
Topics: Acute Disease; Animals; Diuretics; Dogs; Drug Synergism; Furosemide; Heart Failure; Injections; Kidney; Microspheres; Papaverine; Renal Artery; Renal Circulation; Vasodilator Agents | 2001 |
Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
Topics: Bile Acids and Salts; Body Fluids; Furosemide; Gastrointestinal Contents; Hydrogen-Ion Concentration; Intestines; Lipids; Micelles; Morpholines; Niflumic Acid; Papaverine; Rivaroxaban; Solubility; Thiophenes | 2013 |